₹ 884.00
-2.55 (-0.29%)
O
Orchid Pharma
₹ 884.00
Orchid Pharma Share Price Today
Orchid Pharma (ORCHPHARMA) share price is trading at ₹884.00 on the NSE as of November 9, 2026 at 03:29 PM, down by 0.29% from its previous close of ₹886.55. In todays trading session ORCHPHARMA reached a high of 914.00 and low of 881.05. The average traded price for today is 896.80. The 50 DMA stands at 951.41 and 200 DMA is at 816.88. Looking at intraday trend, the stock is moving sideways.
Stock Overview
- Symbol : ORCHPHARMA
- Open : ₹881.55
- Previous Close : ₹886.55
- Day's Range : ₹881.05 – ₹914.00
- 52-Week Range : ₹480.00 – ₹1,143.50
Get 20+ Chart Types, 180+ Indicators, 80+ Drawing Tools & Create Custom Indicators for FREE.
ORCHPHARMA Stock Performance
Markets Today
High
914.00
Low
881.05
Open at
881.55
Prev Close
886.55
Volumes
39,882
Avg Price
896.80
Lower Circuit
707.20
Upper Circuit
1,060.80
Last Traded Details
Quantity
8
Time
15:29:56
Price Movement
Historical Performance
3 M High
1,143.50
3 M Low
809.05
1 Yr High
1,143.50
1 Yr Low
480.00
3 Yr High
1,997.40
3 Yr Low
480.00
5 Yr High
1,997.40
5 Yr Low
265.00
1-Year Performance
ORCHPHARMA Pros and Cons
Revenue grows from ₹173 Cr in Q1 FY26 to ₹304.17 Cr in Q1 FY27 over five quarters, confirming strong sales momentum.
Interest expense falls from ₹3 Cr in Q1 FY26 to ₹2 Cr in Q1 FY27, lowering debt servicing costs.
Profit before tax recovers from -₹6 Cr in Q3 FY26 to ₹2.65 Cr in Q1 FY27, showing margin repair.
Exceptional items drop from ₹7 Cr in Q3 FY26 to ₹1 Cr in Q1 FY27, clearing one-time charges.
Employee expenses rise from ₹22 Cr in Q1 FY26 to ₹27 Cr in Q1 FY27, keeping headcount costs controlled.
Cost of goods sold rises from ₹99 Cr in Q1 FY26 to ₹204 Cr in Q1 FY27, squeezing production margins.
EBITDA margin falls from 17% in Q1 FY26 to 8% in Q1 FY27, reflecting pricing pressure.
Other expenses jump from ₹38 Cr in Q1 FY26 to ₹57.83 Cr in Q1 FY27, adding unexpected operational costs.
Other income drops from ₹16 Cr in Q1 FY26 to ₹1.83 Cr in Q1 FY27, reducing ancillary earnings.
Employee benefits expense surges from 13% in Q1 FY26 to 28.04% in Q1 FY27, weighing on overall profitability.
ORCHPHARMA Analyst Rating
Hold
Analysts have suggested that investors can
Hold this Stock
- By Refinitiv from 1 analysts
Buy
0%
Hold
100%
Sell
0%
Get forecast for Price, ROA & ROE based on analyst ratings.
ORCHPHARMA Share Price History
ORCHPHARMA Fundamentals
Company Valuation
Market Cap (₹ Cr.)
5,294
PE Ratio
493.90
PB Ratio
3.38
Dividend Yield
-
ROE
0.68%
ROCE
1.10%
Book Value (₹)
261.22
Face Value (₹)
10.00
Analyse ORCHPHARMA with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Dec 2025 | Mar 2026 | Jun 2026 | Aug 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 69.84% | 69.84% | 69.84% | 74.45% | 74.45% |
| Domestic Institutional Investors (DII) | 19.39% | 20.25% | 20.75% | 17.54% | 17.44% |
| Foreign Institutional Investors (FII) | 1.17% | 0.87% | 0.81% | 0.93% | 0.93% |
| Public Investors | 6.76% | 6.58% | 6.21% | 5.12% | 5.26% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
Orchid Pharma Return Calculator
Note: Past profits do not guarantee future returns.
ORCHPHARMA Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
ORCHPHARMA Technicals
Moving Averages
Technical Indicators
Summary of Technical Indicators for ORCHPHARMA
Margin on ORCHPHARMA
*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).
ORCHPHARMA Financials Summary
In Crores
ORCHPHARMA Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Corporate Actions
The above dates are ex-dates.
Check ORCHPHARMA latest Company Filings, Investor Presentation & Conference Call details.
ORCHPHARMA Revenue Growth
All values are in Crores
Revenue
Profit
Loss
ORCHPHARMA Similar Stocks
FAQs on ORCHPHARMA
What is the share price of Orchid Pharma?
What is the 52W high and 52W low of Orchid Pharma?
What is the return on Orchid Pharma share?
- Past 1 year: 5.04%
- Past 3 years: 62.95%
- Past 5 years: 117.68%
What is the PE and PB Ratio of Orchid Pharma?
What is the EPS of Orchid Pharma?
What is the shareholding pattern of Orchid Pharma?
- DIIs - 17.44%
- FII - 0.93%
- Promoters - 74.45%
- Public Investors 5.26%
- Goverenment - 0.00%
How to buy Orchid Pharma shares online?
How to buy Orchid Pharma shares on Dhan?
- Download the Dhan App to Open a Demat Account
- Navigate to the “Money Tab”
- Add money to your account
- Search for Orchid Pharma share
- Tap on “Buy”
